During a retroactive review of past treatment events for potential adverse events, conducted as a capa in response to a recent fda inspection, a reportable adverse event was discovered.Zoll customer support was notified via download data that a (b)(6) female pt was treated.Further investigation determined that the pt passed away while in the hospital.Ventricular tachycardia (vt) with cpr artifact was detected at 16:43:52.The lifevest delivered a treatment at 16:46:57 during cpr artifact.The cpr artifact contributed to the false detection.A second treatment was delivered at 16:47:34 during vt (267 bpm).The treatment was unable to convert the arrhythmia.A third treatment was delivered at 16:48:05 during vt (267).The treatment converted the arrhythmia to an idioventricular rhythm (120 bpm).The pt's rhythm degraded to asystole several hours later and the pt passed away.
|